TGFB1 and diabetic kidney disease: For instance, miR-30c and miR-141 mitigate EMT in TECs by antagonizing TGF-β1 signaling, while miR-122-5p supplementation alleviates tubular injury and interstitial fibrosis in preclinical DKD models [178,179,180].